Phreesia, Inc.
NYSE:PHRMedical - Healthcare Information Services
+$0.08 today
- Market cap
- $760.99M
- Beta
- 0.88
- P/E (TTM)
- 62.6
- EPS (TTM)
- $0.15
Volume 0.86M
Average 1.97M
PHR Common Stock Issued
Cash raised by issuing new shares.
Phreesia, Inc.NYSE: PHR
Common Stock Issued · Q1 FY2027 · quarter ended Apr 2026
Common stock issued growth accelerates
Q1 FY2027 common stock issued of $653K rose 410.2% year over year, ahead of the +245.4% change in trailing-twelve-month common stock issued. Sequentially, it fell 15.2% from the prior quarter. Over 3 fiscal years it compounded at -8.1% a year.
Context
- Common stock issued amounted to 0.8% of revenue in FY2026, down 0.1 pp from a year earlier.
- Common stock issued increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +410.2% holds above the trailing-twelve-month pace of +245.4%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Common Stock Issued history
USD · from the cash flow
- Latest · FY2026
- 3.83M USD
- Year-over-year change
- -2.7%
- 4-year CAGR
- -64.7%
| Period | Period end | Common Stock Issued | YoY change |
|---|---|---|---|
| FY2026 | 2026-01-31 | 3.83M | -2.7% |
| FY2025 | 2025-01-31 | 3.93M | — |
| FY2024 | 2024-01-31 | 0 | -100.0% |
| FY2023 | 2023-01-31 | 4.92M | -98.0% |
| FY2022 | 2022-01-31 | 245.81M | — |
Common Stock Issued vs competitors
How PHR compares with its peers on the latest reported figures
- PHR's LTM Apr 2026 common stock issued of $3.58M is the 6th largest of the 11 companies compared; the peer median is $3.78M.
- Its year-over-year change of +245.4% is the 2nd highest of 10, against a peer median of -50.9%.
- Common stock issued amounts to 0.7% of revenue for PHR, versus a peer median of 0.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $172.23M | +4286.9% | +360.7% | 60.8% | |
| LTM Jan 2026 | $149.29M | — | — | 178.3% | |
| LTM Sep 2026 | $24.81M | -50.5% | +25.1% | 9.4% | |
| LTM Mar 2026 | $16.36M | -57.8% | -25.1% | 1.3% | |
| LTM Mar 2026 | $4.66M | -50.9% | +23.2% | 0.7% | |
| LTM Apr 2026 | $3.58M | +245.4% | -8.1% | 0.7% | |
| LTM Aug 2026 | $2.9M | -32.9% | +10.2% | 0.3% | |
| LTM Mar 2026 | $2.72M | -63.5% | -37.1% | 0.1% | |
| LTM Mar 2026 | $765K | -111.5% | — | 0.1% | |
| LTM Sep 2026 | $212K | -90.4% | — | 0.1% | |
| LTM Mar 2026 | $208K | +3.0% | -54.6% | 0.2% | |
| Peer median (excluding PHR) | $3.78M | -50.9% | +10.2% | 0.5% | |
Competitors are the stored peer set for PHR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Jan 2022 | FY2023 Jan 2023 | FY2024 Jan 2024 | FY2025 Jan 2025 | FY2026 Jan 2026 |
|---|---|---|---|---|---|
| Net Income | (118.16M) | (176.15M) | (136.89M) | (58.53M) | 2.31M |
| Depreciation & Amortization | 21.3M | 25.3M | 29.49M | 27.89M | 31.45M |
| Deferred Income Tax | 143K | 434K | 228K | 214K | (13.27M) |
| Stock-Based Compensation | 36.14M | 58.78M | 71.7M | 66.98M | 67.45M |
| Change in Working Capital | (18.57M) | (3.86M) | (1.64M) | (6.49M) | (14.09M) |
| Accounts Receivables | (10.22M) | (11.13M) | (11.21M) | (8.81M) | (10.15M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 2.88M | 4.77M | (1.99M) | (3.23M) | 5.26M |
| Other Working Capital | (11.24M) | 2.5M | 11.56M | 5.55M | (9.2M) |
| Other Non-Cash Items | 4.43M | 5.37M | 4.73M | 2.33M | 4.96M |
| Operating Cash Flow | (74.71M) | (90.12M) | (32.38M) | 32.38M | 78.81M |
| Capital Expenditures | (30.81M) | (26.2M) | (25.1M) | (24.09M) | (11.1M) |
| Acquisitions (Net) | (34.42M) | 0 | (14.57M) | 0 | (153.19M) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 15.71M |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (12.39M) | (21.47M) | (19.29M) | (15.38M) | (13.3M) |
| Investing Cash Flow | (65.23M) | (26.2M) | (39.67M) | (24.09M) | (161.88M) |
| Debt Repayment | (4.27M) | (5.95M) | (6.78M) | (7.81M) | 83.18M |
| Common Stock Issued | 245.81M | 4.92M | 0 | 3.93M | 3.83M |
| Common Stock Repurchased | (9M) | (19.38M) | (12.18M) | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 2.42M | (397K) | 1.84M | (7.61M) | (14.15M) |
| Financing Cash Flow | 234.97M | (20.8M) | (17.12M) | (11.49M) | 72.85M |
| Effect of Forex Changes | 0 | 0 | 0 | (106K) | (176K) |
| Net Change in Cash | 95.03M | (137.13M) | (89.16M) | (3.3M) | (10.39M) |
| Free Cash Flow | (105.52M) | (116.33M) | (57.48M) | 8.29M | 67.71M |
Phreesia, Inc.
NYSE:PHR
Intrinsic Alpha fair value
Locked
Current Price
$12.26
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.